Axsome director exercises 1,429 RSUs into stock
Axsome Therapeutics director Roger Jeffs reported a routine equity compensation event.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Axsome Therapeutics director Roger Jeffs reported a routine equity compensation event. On June 8, 2026, he exercised 1,429 restricted stock units, which converted into 1,429 shares of common stock on a one-for-one basis. These RSUs were granted on June 6, 2025 and vested after one year. Following the conversion, Jeffs directly holds 58,939 shares of Axsome common stock, and no shares were reported as sold in this filing.
Insider Trade Summary
1,429 shares exercised/converted
Exercise
2 txns
Insider
JEFFS ROGER
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,429 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,429 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 0 contracts (Direct);
Common Stock — 58,939 shares (Direct)
Footnotes (2)
- F1. On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant.
- F2. Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
Key Figures
RSUs exercised: 1,429 units
Common shares received: 1,429 shares
Post-transaction holdings: 58,939 shares
+2 more
5 metrics
RSUs exercised
1,429 units
Restricted stock units converted on June 8, 2026
Common shares received
1,429 shares
One-for-one RSU conversion into common stock
Post-transaction holdings
58,939 shares
Common stock directly held after RSU conversion
Grant date of RSUs
June 6, 2025
1,429 RSUs granted to Roger Jeffs
Vesting schedule
1-year cliff
All 1,429 RSUs vested on one-year anniversary of grant
Key Terms
Restricted Stock Units, RSUs, derivative security, Form 4
4 terms
Restricted Stock Units financial
"On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Restricted stock units ("RSUs") convert into common stock on a one-for-one basis."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Axsome Therapeutics (AXSM) report for Roger Jeffs?
Axsome Therapeutics director Roger Jeffs exercised 1,429 restricted stock units, receiving 1,429 shares of common stock. The transaction reflects conversion of equity compensation, with no reported share sales in this Form 4.
When were Roger Jeffs’ RSUs in Axsome Therapeutics (AXSM) granted and vested?
Roger Jeffs was granted 1,429 restricted stock units on June 6, 2025. According to the footnotes, all of these RSUs vested on the one-year anniversary of the grant date, triggering their conversion into common shares.
What are Roger Jeffs’ Axsome Therapeutics (AXSM) holdings after this RSU conversion?
After the RSU conversion, Roger Jeffs directly holds 58,939 shares of Axsome Therapeutics common stock. This figure, reported in the Form 4, reflects his position following the June 8, 2026 transaction.
How does the Form 4 describe the Axsome Therapeutics (AXSM) RSU transaction type?
The Form 4 classifies the RSU event with transaction code “M,” described as the exercise or conversion of a derivative security. It records the move from 1,429 RSUs to 1,429 common shares as an acquisition-type transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates